Skip to content
Homepage
Author:
Talawar Therapeutics
Posted Date:
July 20, 2026
Talawar Therapeutics Appoints Steve Migausky as Chief Legal and Administrative Officer
Talawar Therapeutics
July 20, 2026
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Talawar Therapeutics
June 29, 2026
